Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Baxter
AstraZeneca
Mallinckrodt
Dow

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tocotrienol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Tocotrienol?

Tocotrienol is an investigational drug.

There have been 18 clinical trials for Tocotrienol. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.

The most common disease conditions in clinical trials are Ovarian Neoplasms, Pancreatic Neoplasms, and Atrial Fibrillation. The leading clinical trial sponsors are Vejle Hospital, H. Lee Moffitt Cancer Center and Research Institute, and Texas Tech University Health Sciences Center.

There are thirty-one US patents protecting this investigational drug and one hundred and ninety-nine international patents.

Recent Clinical Trials for Tocotrienol
TitleSponsorPhase
Bevacizumab and Tocotrienol in Recurrent Ovarian CancerVejle HospitalPhase 2
Safety and Efficacy of Tocotrienols in Post-CABG Atrial FibrillationINSTITUT JANTUNG NEGARAPhase 2/Phase 3
Safety and Efficacy of Tocotrienols in Post-CABG Atrial FibrillationMonash University MalaysiaPhase 2/Phase 3

See all Tocotrienol clinical trials

Clinical Trial Summary for Tocotrienol

Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol

See all Tocotrienol clinical trials

US Patents for Tocotrienol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tocotrienol   Start Trial Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders Bristol-Myers Squibb Company (New York, NY)   Start Trial
Tocotrienol   Start Trial Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders Bristol-Myers Squibb Company (New York, NY)   Start Trial
Tocotrienol   Start Trial Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate PPG Industries, Inc. (Pittsburgh, PA)   Start Trial
Tocotrienol   Start Trial Substrates coated with antioxidant compositions and method for inhibiting the oxidation of such compositions applied to a substrate PPG Industries, Inc. (Pittsburgh, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tocotrienol

Drugname Country Document Number Estimated Expiration Related US Patent
Tocotrienol Canada 2026713 2009-10-04   Start Trial
Tocotrienol European Patent Office 0421419 2009-10-04   Start Trial
Tocotrienol Hungary 207442 2009-10-04   Start Trial
Tocotrienol Hungary 906297 2009-10-04   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Merck
Dow
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.